(Q40855642)

24 September 2017

1 reference

title

Antibacterial agents--phagocytes: new concepts for old in immunomodulation (English)

1 reference

24 September 2017

Labro MT

1

1 reference

24 September 2017

1 April 1998

1 reference

International Journal of Antimicrobial Agents

24 September 2017

1 reference

24 September 2017

10

1 reference

24 September 2017

1

1 reference

24 September 2017

11-21

1 reference

Vaccination in the 21st century

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Mononuclear phagocytes: tissue distribution and functional heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Secretory products of phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Innate immunity: impact on the adaptive immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

The instructive role of innate immunity in the acquired immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Oxygen-dependent microbial killing by phagocytes (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Neutrophil-derived Oxidants and Proteinases as Immunomodulatory Mediators in Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Signaling mechanisms in human neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Infection of phagocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Neutrophils and Adult Respiratory Distress Syndrome: Two Interlocking Perspectives in 1991

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Antibiotics and neutrophil function--potential immunomodulating activities

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Immunomodulation by antibacterial agents. Is it clinically relevant?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Interactions between antimicrobial drugs and phagocytes: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Antimicrobial drugs, microorganisms, and phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Antibiotics as biological response modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

In-vitro effects of cefodizime on leucocyte functions and colony formation from granulocyte-monocyte progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Effects of cefotaxime and cefodizime on human granulocyte functions in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Effect of RO 23-9424, cefotaxime and fleroxacin on functions of human polymorphonuclear cells and cytokine production by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Effect of newer quinolones on the extra- and intra-cellular chemiluminescence response of human polymorphonuclear leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

The effect of quinolones on the intracellular killing of Staphylococcus aureus in neutrophil granulocytes [published erratum appears in J Antimicrob Chemother 1997 Sep;40(3):462]

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Oxidative metabolic products released from polymorphonuclear leukocytes in middle ear fluid during experimental pneumococcal otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Cytoprotection against neutrophil-delivered oxidant attack by antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Oxidant-scavenging activities of ampicillin and sulbactam and their effects on neutrophil functions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Cefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vitro immunomodulatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Antibiotics and energy delivery to the phagocytosis-associated respiratory burst in chronic hemodialysis patients: a comparison of cefodizime and cotrimoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Cefodizime modulates in vitro tumor necrosis factor-alpha, interleukin-6 and interleukin-8 release from human peripheral monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Activity of antibiotics against microorganisms ingested by mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Intracellular bioactivity of macrolides

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Interactions of the oxygen-dependent antimicrobial system of the human neutrophil with difloxacin, ciprofloxacin, pefloxacin and fleroxacin in the intraphagocytic eradication of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Carrier-mediated system for pefloxacin uptake in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Regulation of ciprofloxacin uptake in human promyelocytic leukemia cells and polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Liposomes and nanoparticles in the treatment of intracellular bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Enhancement of antibacterial activity of clofazimine against Mycobacterium avium-Mycobacterium intracellulare complex infection induced by IFN-gamma is mediated by TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Stimulation with cytokines enhances penetration of azithromycin into human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

The use of macrolide antibiotic substances in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Anti-inflammatory activity of macrolides: a new therapeutic potential?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Macrolides for the treatment of Pseudomonas aeruginosa infections?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Anti-inflammatory effects of macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Treatment of early rheumatoid arthritis with rifampicin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Rifamycin SV administered by intra-articular infiltrations shows disease modifying activity in patients with pauci- or polyarticular juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system. A possible correlation with their anti-inflammatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Apparent involvement of phospholipase A2, but not protein kinase C, in the pro-oxidative interactions of clofazimine with human phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Sulphonamides as anti-inflammatory agents: old drugs for new therapeutic strategies in neutrophilic inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Sulfonamides as antiinflammatory agents in the treatment of Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

The Anticollagenolytic Potential of Lymecycline in the Long‐Term Treatment of Reactive Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

The effect of antimicrobial agents on the induction of tumour necrosis factor by alveolar macrophages in vitro in response to endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

Modulatory effect of antibiotics on cytokine production by human monocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900012-0

7 January 2021

10.1016/S0924-8579(98)00012-0

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9624539